| 0 |
MYOGLOBINAEMIA |
1 |
0.0085 |
| 1 |
FEEDING TUBE COMPLICATION |
1 |
0.0032 |
| 2 |
CSF TEST ABNORMAL |
1 |
0.0020 |
| 3 |
ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED |
1 |
0.0013 |
| 4 |
TORSADE DE POINTES |
6 |
0.0008 |
| 5 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
1 |
0.0006 |
| 6 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 7 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 8 |
VENTRICULAR TACHYCARDIA |
5 |
0.0003 |
| 9 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 10 |
BUNDLE BRANCH BLOCK LEFT |
1 |
0.0002 |
| 11 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 12 |
ELECTROCARDIOGRAM QT PROLONGED |
5 |
0.0001 |
| 13 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 14 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 15 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 16 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 17 |
BREAST CANCER METASTATIC |
1 |
0.0001 |
| 18 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 19 |
MYOCARDITIS |
1 |
0.0001 |
| 20 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 21 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 22 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 23 |
DIALYSIS |
1 |
0.0001 |
| 24 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 25 |
FLUID OVERLOAD |
1 |
0.0001 |
| 26 |
COAGULOPATHY |
1 |
0.0001 |
| 27 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 28 |
TOOTHACHE |
1 |
0.0001 |
| 29 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 30 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 31 |
TASTE DISORDER |
1 |
0.0000 |
| 32 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 33 |
ATRIAL FIBRILLATION |
4 |
0.0000 |
| 34 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 35 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 36 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 37 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 38 |
HYPERKALAEMIA |
1 |
0.0000 |
| 39 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 40 |
BLINDNESS |
1 |
0.0000 |
| 41 |
CARDIAC ARREST |
2 |
0.0000 |
| 42 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 43 |
POLLAKIURIA |
1 |
0.0000 |
| 44 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 45 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 46 |
COMA |
1 |
0.0000 |
| 47 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 48 |
RENAL FAILURE |
2 |
0.0000 |
| 49 |
NEUTROPENIA |
2 |
0.0000 |
| 50 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 51 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 52 |
DRUG INTERACTION |
2 |
0.0000 |
| 53 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 54 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 55 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 56 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 57 |
HYPOTENSION |
2 |
0.0000 |
| 58 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 59 |
SEPSIS |
1 |
0.0000 |
| 60 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 61 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 62 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 63 |
DEHYDRATION |
1 |
0.0000 |
| 64 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 65 |
HOSPITALISATION |
1 |
0.0000 |
| 66 |
TREMOR |
1 |
0.0000 |
| 67 |
MUSCLE SPASMS |
1 |
0.0000 |
| 68 |
ASTHENIA |
2 |
0.0000 |
| 69 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 70 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 71 |
CONSTIPATION |
1 |
0.0000 |
| 72 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 73 |
FEELING ABNORMAL |
1 |
0.0000 |
| 74 |
INSOMNIA |
1 |
0.0000 |
| 75 |
DYSPNOEA |
2 |
0.0000 |
| 76 |
FATIGUE |
1 |
0.0000 |